CompletedNCT01748955
Paroxetine or Bupropion and Brain Reward Activity in Depression
About this title
Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study
Read the official source — NCT01748955Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJune 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 15
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01748955
- Official title
Show the full official title
SSRI Versus Bupropion in High-Risk Major Depressive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Paroxetine CR for Major Depressive Episode and Bupropion XL for Major Depressive Episode.
Who was this study for?
Listed age limits: 18 years to 65 years.
